Stock Market News

Jury rules in favor of Bayer’s Monsanto in Philadelphia trial over Roundup

2024.09.11 22:00

© Reuters. FILE PHOTO: The 120 metres high Bayer Cross, logo of German pharmaceutical and chemical maker Bayer AG, consisting of 1710 LED glass bulbs is seen outside the industrial park

(Reuters) – Bayer (OTC:)’s Monsanto (NYSE:) unit said on Wednesday that a Philadelphia Court jury reached a verdict in the Young Roundup product liability trial in their favor.

Bayer bought Monsanto for $63 billion in 2018, and has faced extensive and costly litigation over whether Monsanto’s Roundup weed killer causes cancer.



Source link

Related Articles

Back to top button